Alvotech
ALVO
5.85
-0.29
-4.72%
Alvotech
US · ALVO
#2709 by market cap
Listed 2020
5.85
-0.29
-4.72%
Live - 5344 symbols - heartbeat 203s ago
· 2026-10-08 05:57
Pre-market
6.16
+5.25%
After-hours
5.83
-0.43%
Overnight
6.00
+2.56%
- Market cap
- 2.09B
- P/E (TTM)i
- -9.59
- P/Bi
- -10.34
- EPSi
- 0.10
- Div yieldi
- 0.00%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on ALVO?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 7 years
Margins
- Gross margin
- 59.82%
- Operating margin
- 13.34%
- Net margin
- 4.76%
Key ratios & quality
- Enterprise valuei
- 3.23B
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 31.92M | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | 66.62M | 36.77M | 18.93M | -69.42M | 304.37M | 350.76M |
| Selling & admin expenses | 48.57M | 58.91M | 84.13M | 183.39M | 73.04M | 61.45M | 84.92M |
| Research & development | 95.56M | 148.07M | 191.01M | 180.62M | 210.83M | 171.31M | 184.19M |
| Operating profit | -61.45M | -137.54M | -235.46M | -346.44M | -354.86M | 69.64M | 78.21M |
| Pretax profit | -209.39M | -291.77M | -149.20M | -551.65M | -651.05M | -217.56M | 136.35M |
| Tax | 491.00K | -121.73M | -47.69M | -38.07M | -99.32M | 14.30M | 108.43M |
| Net profit | -209.88M | -170.04M | -101.50M | -513.58M | -551.73M | -231.86M | 27.92M |
| Basic EPS | -1 | -1 | 0 | -3 | -2 | -1 | 0 |
| Diluted EPS | -0.86 | -0.70 | -0.42 | -2.60 | -2.43 | -0.87 | 0.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | 67.32M | 99.41M | 78.74M | 105.29M | 59.78M | 53.58M |
| Selling & admin expenses | 18.61M | 26.74M | 25.92M | 13.65M | 25.67M | 43.56M |
| Research & development | 38.17M | 54.72M | 51.62M | 39.69M | 24.51M | 21.86M |
| Operating profit | 10.58M | 18.06M | 1.31M | 48.26M | 9.67M | -11.71M |
| Pretax profit | 93.42M | 9.31M | -6.09M | 39.70M | 986.00K | -66.76M |
| Tax | -16.26M | -22.73M | -835.00K | 148.25M | -44.00K | 59.00K |
| Net profit | 109.68M | 32.04M | -5.25M | -108.55M | 1.03M | -66.82M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.35 | 0.11 | -0.03 | -0.37 | 0.00 | -0.19 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | -- | 86.16M | 119.82M | 230.74M | 194.84M | 455.02M | 574.02M |
| Cash & ST investments | -- | 31.69M | 17.56M | 66.43M | 11.16M | 51.43M | 172.36M |
| Inventory | -- | 9.65M | 39.06M | 71.47M | 74.43M | 127.89M | 220.05M |
| Total assets | -- | 474.42M | 597.98M | 828.44M | 950.09M | 1.22B | 1.49B |
| Total current liabilities | -- | 50.98M | 111.84M | 167.29M | 260.95M | 193.40M | 304.08M |
| Short-term debt | -- | 7.98M | 10.07M | 25.08M | 47.71M | 42.22M | 49.00M |
| Long-term debt | -- | 565.40M | 398.14M | 744.65M | 922.13M | 1.04B | 1.26B |
| Total liabilities | -- | 1,341,665,000.00 | 733,589,000.00 | 1,392,859,000.00 | 1,882,583,000.00 | 1,634,171,000.00 | 1,771,586,000.00 |
| Total equity | -- | -867.24M | -135.61M | -564.42M | -932.49M | -412.77M | -284.49M |
| Retained earnings | -- | -1.04B | -1.14B | -1.65B | -2.21B | -2.44B | -2.41B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 458.87M | 509.46M | 432.01M | 574.02M | 455.98M | 544.97M |
| Cash & ST investments | 38.54M | 151.45M | 42.85M | 172.36M | 63.83M | 142.75M |
| Inventory | 142.07M | 155.49M | 207.73M | 220.05M | 228.02M | 226.55M |
| Total assets | 1.25B | 1.39B | 1.41B | 1.49B | 1.42B | 1.59B |
| Total current liabilities | 265.81M | 279.75M | 304.07M | 304.08M | 259.78M | 331.18M |
| Short-term debt | 43.82M | 59.62M | 56.02M | 49.00M | 55.64M | 53.77M |
| Long-term debt | 1.06B | 1.07B | 1.08B | 1.26B | 1.27B | 1.26B |
| Total liabilities | 1,547,749,000.00 | 1,566,082,000.00 | 1,585,941,000.00 | 1,771,586,000.00 | 1,703,480,000.00 | 1,778,947,000.00 |
| Total equity | -302.29M | -173.33M | -176.76M | -284.49M | -282.31M | -191.48M |
| Retained earnings | -2.33B | -2.30B | -2.30B | -2.41B | -2.41B | -2.48B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -88.55M | -74.30M | -228.17M | -312.39M | -312.19M | -236.84M | -50.20M |
| Depreciation & amortization | 14.61M | 16.42M | 18.20M | 20.41M | 24.21M | 31.30M | 37.85M |
| Free cash flow | -96.60M | -86.28M | -268.80M | -361.39M | -358.66M | -293.84M | -146.33M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 30.69M | 34.39M | 185.86M | 9.83M | 136.88M | 150.45M | 82.48M |
| Ending cash balance | 67.40M | 31.69M | 17.56M | 66.43M | 11.16M | 51.43M | 172.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 12.55M | 55.74M | -55.58M | -62.91M | -60.43M | -19.79M |
| Depreciation & amortization | 8.26M | 8.90M | 10.28M | 10.41M | 10.29M | 10.33M |
| Free cash flow | -10.82M | 27.14M | -83.97M | -78.68M | -106.62M | -64.56M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 38.54M | 151.45M | 42.85M | 172.36M | 63.83M | 142.75M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | -- | -35.84 | -18.93 | -72.01 | -62.04 | -21.36 | 2.06 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -356.01 | -291.68 | -98.52 | -571.09 | -566.40 | -12.98 | 46.60 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | -- | 1.69 | 1.07 | 1.38 | 0.75 | 2.35 | 1.89 |
| Quick ratioi | -- | 1.38 | 0.64 | 0.82 | 0.38 | 1.57 | 1.07 |
| Debt / assetsi | -- | 142.67 | 87.47 | 97.18 | 113.20 | 97.45 | 97.45 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | -1.19 | -1.99 | -0.32 | -6.12 | -3.89 | -0.41 | 2.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 37.53 | 11.13 | 137.03 | 91.85 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 8.37 | 5.15 | 5.26 | 2.06 | -6.05 | -12.05 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 18.18 | 30.97 | 13.48 | 46.60 | 33.26 | 22.45 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.73 | 1.82 | 1.42 | 1.89 | 1.76 | 1.65 |
| Quick ratioi | 1.01 | 1.19 | 0.54 | 1.07 | 0.76 | 0.83 |
| Debt / assetsi | 98.51 | 91.04 | 90.99 | 97.45 | 102.54 | 91.45 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 19.49 | 1.24 | 3.11 | 2.00 | 1.31 | 0.77 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Development revenue (over time revenue recognition) is the largest reported line at 51.66% of revenue, across 2 reported segments.
- Product and service revenue (point in time revenue recognition) follows at 48.34%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Development revenue (over time revenue recognition)51.66%
Product and service revenue (point in time revenue recognition)48.34%
Quote time 2026-10-08 05:57:06 · For reference only, not investment advice and not tailored to your situation.